Shukra Pharmaceuticals Ltd — Board Meeting, 13-08-2025: Board Meeting

Shukra Pharmaceuticals' Board has approved its financial results for the quarter ended June 30, 2025. The company reported a significant increase in revenue from operations, reaching Rs 5.39 Cr, up from Rs 3.18 Cr in the same quarter last year. Net profit for the period also saw a healthy jump to Rs 1.03 Cr, compared to Rs 0.49 Cr previously. Earnings per share rose to Rs 0.02. The Board also reviewed the company's business performance, providing key insights into its operational strength and growth trajectory.